Agilis Pharmaceuticals LLP

Agilis Pharmaceuticals LLP - paper in Kandivali West, Maharashtra, India. Directors, charges & compliance details.
LLPIN ABB-8641 Incorporated 25 July 2022 ROC Mumbai HQ Kandivali West, Maharashtra, India
Pending Strike Off Limited Liability Partnership paper
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
Locked
In full report
Net profit · Latest
Locked
In full report
Contribution obligation
₹1 Lakh
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
None
Secured borrowings
Company age
4 yrs
Est. 2022
Last AGM
31 Mar 2023
Annual general meeting

About Agilis Pharmaceuticals LLP

Data last updated:

Agilis Pharmaceuticals LLP is a limited liability partnership company based in Kandivali West, Maharashtra, India. The LLP is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the LLP may be struck off soon. It specialises in paper and paper products, a part of the broader paper and packaging sector. Incorporated on 25 July 2022.

Registered with ROC Mumbai under LLPIN ABB-8641.

Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners Mitesh Jayantilal Doshi and Ruchi Nimish Siria.

Office: Sector 3, Kandivali West, Maharashtra.

The LLP is under the process of being struck off by the Registrar of Companies. This typically indicates non-filing of statutory returns, and the LLP may soon cease to exist as a legal entity.

Company Details of Agilis Pharmaceuticals LLP
LLPIN ABB-8641
Incorporation Date 25 July 2022
Total Obligation of Contribution ₹1 Lakh
ROC Mumbai
Company Status Under Process of Striking Off
Date of Last AGM 31 March 2023
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Off – 136 Kesar Residency Chs Ltd, Sector 3 Near Charkop Market, Kandivali West, Maharashtra, India – 400067
  • Industry
    Paper, Paper & Paper Products, Manufacturing
Company report
Agilis Pharmaceuticals LLP - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Agilis Pharmaceuticals LLP report

Financials, compliance, directors, charges, ownership and filings for Agilis Pharmaceuticals LLP in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Agilis Pharmaceuticals LLP

Agilis Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Mitesh Jayantilal DoshiDesignated Partner25 Jul 20224 Years 2 MonthsCurrent
Ruchi Nimish SiriaDesignated Partner25 Jul 20224 Years 2 MonthsCurrent

Financials of Agilis Pharmaceuticals LLP

Premium access

Ten-year financial statements for Agilis Pharmaceuticals LLP

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Agilis Pharmaceuticals

Agilis Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Agilis Pharmaceuticals

Employment history and EPFO contributions of people linked to Agilis Pharmaceuticals.

Premium access

Employee and EPFO history for Agilis Pharmaceuticals LLP

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Agilis Pharmaceuticals

Premium access

GST registrations and filing compliance for Agilis Pharmaceuticals LLP

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Agilis Pharmaceuticals

Premium access

Credit ratings, litigation, and regulatory alerts for Agilis Pharmaceuticals LLP

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Agilis Pharmaceuticals

Premium access

MSME payment history for Agilis Pharmaceuticals LLP

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Agilis Pharmaceuticals

Premium access

Corporate group structure for Agilis Pharmaceuticals LLP

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Agilis Pharmaceuticals

Premium access

MCA filings and documents for Agilis Pharmaceuticals LLP

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Agilis Pharmaceuticals

Activity
31 Mar 2023
Agilis Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Directors
25 Jul 2022
Mitesh Jayantilal Doshi was appointed as a Designated Partner on 25 Jul 2022 & has been associated with this company since 4 years 2 months.
Directors
25 Jul 2022
Ruchi Nimish Siria was appointed as a Designated Partner on 25 Jul 2022 & has been associated with this company since 4 years 2 months.
Activity
25 Jul 2022
Agilis Pharmaceuticals Llp was registered on 25 Jul 2022 with Roc Mumbai & aged 4 years 2 months as per MCA records.

Frequently Asked Questions about Agilis Pharmaceuticals LLP

Agilis Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the LLP from the register, typically due to non-filing of statutory returns. This process is not yet final, but the LLP may be struck off soon. Caution is advised before entering into any agreements with this entity.

Agilis Pharmaceuticals is a company pending strike off, currently registered as a limited liability partnership in the paper sector based in Kandivali West, Maharashtra, India. It was incorporated on 25 July 2022 and is registered under LLPIN ABB-8641. The LLP may be struck off soon - caution is advised.

The current designated partners of Agilis Pharmaceuticals are:

The LLPIN (Limited Liability Partnership Identification Number) of Agilis Pharmaceuticals is ABB-8641. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

The primary industry of Agilis Pharmaceuticals is paper. The LLP specifically operates in paper and paper products.

Agilis Pharmaceuticals can be reached at the registered office: Off – 136 Kesar Residency Chs Ltd, Sector 3 Near Charkop Market, Kandivali West, Maharashtra, India – 400067.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available